TrialFind
Saved trials
Back to results
Completed
Phase 3
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
NCT00096798
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Massachusetts General Hospital
Boston, Massachusetts, United States
View on ClinicalTrials.gov
Official details
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression — TrialFind